Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010The journal of obstetrics and gynaecology research, 2019-02, Vol.45 (2), p.289 [Peer Reviewed Journal]2018 Japan Society of Obstetrics and Gynecology. ;EISSN: 1447-0756 ;DOI: 10.1111/jog.13863 ;PMID: 30426591Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerThe New England journal of medicine, 2023-06, Vol.388 (23), p.2159-2170 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302312 ;PMID: 36972022Full text available |
|
3 |
Material Type: Article
|
Dostarlimab for Primary Advanced or Recurrent Endometrial CancerThe New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2216334 ;PMID: 36972026Full text available |
|
4 |
Material Type: Article
|
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumorsInternational journal of gynecological cancer, 2021-07, Vol.31 (7), p.961-982 [Peer Reviewed Journal]IGCS and ESGO 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. ;2021 IGCS and ESGO 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;IGCS and ESGO 2021. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. 2021 ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-002565 ;PMID: 34112736Full text available |
|
5 |
Material Type: Article
|
Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancerInternational journal of gynecological cancer, 2020-03, Vol.30 (3), p.364-371 [Peer Reviewed Journal]IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-000939 ;PMID: 31980488Full text available |
|
6 |
Material Type: Article
|
Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remainInternational journal of gynecological cancer, 2020-06, Vol.30 (6), p.873-878 [Peer Reviewed Journal]IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-001257 ;PMID: 32241876Full text available |
|
7 |
Material Type: Article
|
Sentinel lymph node biopsy alone in the management of early cervical carcinomaInternational journal of gynecological cancer, 2022-01, Vol.32 (1), p.15-20 [Peer Reviewed Journal]IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-001082 ;PMID: 32546643Full text available |
|
8 |
Material Type: Article
|
Human papillomavirus-independent cervical cancerInternational journal of gynecological cancer, 2022-01, Vol.32 (1), p.1-7 [Peer Reviewed Journal]IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-003014 ;PMID: 34725203Full text available |
|
9 |
Material Type: Article
|
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseInternational journal of gynecological cancer, 2019-05, Vol.29 (4), p.728-760 [Peer Reviewed Journal]The Authors 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 The Authors 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-000308 ;PMID: 31048403Full text available |
|
10 |
Material Type: Article
|
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter studyInternational journal of gynecological cancer, 2020-07, Vol.30 (7), p.1065-1070 [Peer Reviewed Journal]IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. ;2020 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2020 IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;IGCS and ESGO 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. 2020 ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-001135 ;PMID: 32447296Full text available |
|
11 |
Material Type: Article
|
It is time to implement molecular classification in endometrial cancerArchives of gynecology and obstetrics, 2024-03, Vol.309 (3), p.745 [Peer Reviewed Journal]2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;EISSN: 1432-0711 ;DOI: 10.1007/s00404-023-07128-z ;PMID: 37410149Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
FIGO 2023 endometrial cancer staging: too much, too soon?International journal of gynecological cancer, 2024-01, p.ijgc-2023-004981 [Peer Reviewed Journal]2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-004981Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter studyInternational journal of gynecological cancer, 2019-05, Vol.29 (4), p.829-834 [Peer Reviewed Journal]2019 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-000332 ;PMID: 30898938Full text available |
|
14 |
Material Type: Article
|
Management of ovarian masses in pregnancy: patient selection for interventional treatmentInternational journal of gynecological cancer, 2021-06, Vol.31 (6), p.899-906 [Peer Reviewed Journal]IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-001996 ;PMID: 33172924Full text available |
|
15 |
Material Type: Article
|
Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcomaInternational journal of gynecological cancer, 2019-02, Vol.29 (2), p.277-281 [Peer Reviewed Journal]IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology. ;2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2018-000038 ;PMID: 30636710Full text available |
|
16 |
Material Type: Article
|
Complications of HIPEC for ovarian cancer surgery: evaluation over two time periodsInternational journal of gynecological cancer, 2024-01, p.ijgc-2023-004658 [Peer Reviewed Journal]2023 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-004658Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Circulating Inflammation Markers and Risk of Epithelial Ovarian CancerCancer epidemiology, biomarkers & prevention, 2011-05, Vol.20 (5), p.799-810 [Peer Reviewed Journal]2015 INIST-CNRS ;2011 AACR. ;ISSN: 1055-9965 ;ISSN: 1538-7755 ;EISSN: 1538-7755 ;DOI: 10.1158/1055-9965.EPI-10-1180 ;PMID: 21467242 ;CODEN: CEBPE4Full text available |
|
18 |
Material Type: Article
|
Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?International journal of gynecological cancer, 2020-12, Vol.30 (12), p.1864-1870 [Peer Reviewed Journal]IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-001816 ;PMID: 33037109Full text available |
|
19 |
Material Type: Article
|
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trialThe lancet oncology, 2016, Vol.17 (1), p.78-89 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 1, 2016 ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00366-6 ;PMID: 26590673Full text available |
|
20 |
Material Type: Article
|
The role of factor XIII in surgery for advanced stage of epithelial ovarian cancerArchives of gynecology and obstetrics, 2022-05, Vol.305 (5), p.1311-1318 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 1432-0711 ;ISSN: 0932-0067 ;EISSN: 1432-0711 ;DOI: 10.1007/s00404-021-06308-z ;PMID: 34724570Full text available |